Opioid agonist treatment prevents hundreds of suicides: Study Australian research predicts the treatment has prevented around 300 suicide deaths among NSW patients with opioid use disorder.
Private opioid dependence scripts extended The Government will allow GPs to continue issuing private prescriptions until June next year, but the RACGP is calling for a permanent solution.
GPs encouraged to prepare for opioid dependence changes All opioid dependence treatment medicines will be listed on the PBS from next month, in news welcomed by the RACGP.
Opioid treatment study ‘may impact’ future Australian guidelines Results from a clinical trial of extended-release buprenorphine injections reveal high retention and treatment satisfaction.
How can opioid deaths be reduced? New studies further verify the benefits of pharmacotherapy for opioid dependence in greatly reducing all-cause mortality rates.
Who is seeking pharmacotherapy treatment for opioid dependence? Annual data examines who, where and why on a ‘snapshot day’ in 2020, and how treatment has progressed.
Advocates hail ‘game changing’ PBS listing of buprenorphine Harm-reduction advocates have long called for an end to the surprisingly high cost of opioid substitution therapy.
Should GPs be able to prescribe buprenorphine without restriction? As Australia battles a spike in opioid-related deaths, research suggests advantages in much greater availability of pharmacotherapy treatment.